These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17499218)
1. Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids, glycolipids and trans-epithelial passage disturbance. Loiseau N; Debrauwer L; Sambou T; Bouhet S; Miller JD; Martin PG; Viadère JL; Pinton P; Puel O; Pineau T; Tulliez J; Galtier P; Oswald IP Biochem Pharmacol; 2007 Jun; 74(1):144-52. PubMed ID: 17499218 [TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects on sphingoid bases and cytokines in chickens fed diets prepared with fusarium verticillioides culture material containing fumonisins. Grenier B; Schwartz-Zimmermann HE; Caha S; Moll WD; Schatzmayr G; Applegate TJ Toxins (Basel); 2015 Apr; 7(4):1253-72. PubMed ID: 25871822 [TBL] [Abstract][Full Text] [Related]
3. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity. Gopee NV; Sharma RP Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912 [TBL] [Abstract][Full Text] [Related]
4. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389 [TBL] [Abstract][Full Text] [Related]
5. The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Bouhet S; Hourcade E; Loiseau N; Fikry A; Martinez S; Roselli M; Galtier P; Mengheri E; Oswald IP Toxicol Sci; 2004 Jan; 77(1):165-71. PubMed ID: 14600282 [TBL] [Abstract][Full Text] [Related]
6. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417 [TBL] [Abstract][Full Text] [Related]
7. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. Tsunoda M; Sharma RP; Riley RT J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234 [TBL] [Abstract][Full Text] [Related]
8. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. Merrill AH; van Echten G; Wang E; Sandhoff K J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970 [TBL] [Abstract][Full Text] [Related]
9. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. He Q; Kim J; Sharma RP Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051 [TBL] [Abstract][Full Text] [Related]
10. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405 [TBL] [Abstract][Full Text] [Related]
11. A review of the toxic effects and mechanisms of action of fumonisin B1. Stockmann-Juvala H; Savolainen K Hum Exp Toxicol; 2008 Nov; 27(11):799-809. PubMed ID: 19244287 [TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482 [TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics and toxicological effects of single oral dose of fumonisin B1 containing Fusarium verticillioides culture material in weaned piglets. Dilkin P; Direito G; Simas MM; Mallmann CA; Corrêa B Chem Biol Interact; 2010 May; 185(3):157-62. PubMed ID: 20338158 [TBL] [Abstract][Full Text] [Related]
14. Effects of orally administered fumonisin B₁ (FB₁), partially hydrolysed FB₁, hydrolysed FB₁ and N-(1-deoxy-D-fructos-1-yl) FB₁ on the sphingolipid metabolism in rats. Hahn I; Nagl V; Schwartz-Zimmermann HE; Varga E; Schwarz C; Slavik V; Reisinger N; Malachová A; Cirlini M; Generotti S; Dall'Asta C; Krska R; Moll WD; Berthiller F Food Chem Toxicol; 2015 Feb; 76():11-8. PubMed ID: 25475052 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Soriano JM; González L; Catalá AI Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752 [TBL] [Abstract][Full Text] [Related]
16. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699 [TBL] [Abstract][Full Text] [Related]
17. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity. He Q; Riley RT; Sharma RP Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577 [TBL] [Abstract][Full Text] [Related]
18. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Ramasamy S; Wang E; Hennig B; Merrill AH Toxicol Appl Pharmacol; 1995 Aug; 133(2):343-8. PubMed ID: 7645031 [TBL] [Abstract][Full Text] [Related]
19. Activated carbon does not prevent the toxicity of culture material containing fumonisin B1 when fed to weanling piglets. Piva A; Casadei G; Pagliuca G; Cabassi E; Galvano F; Solfrizzo M; Riley RT; Diaz DE J Anim Sci; 2005 Aug; 83(8):1939-47. PubMed ID: 16024715 [TBL] [Abstract][Full Text] [Related]